Final week, there have been two optimistic developments referring to Pfizer (NYSE: PFE) and its German associate BioNTech’s Covid-19 vaccine, and one doable unfavourable improvement. Firstly, Pfizer says based mostly on inside testing that its vaccine can tolerate hotter temperatures www.nasdaq.com
Final week, there have been two optimistic developments referring to Pfizer (NYSE: PFE) and its German associate BioNTech’s Covid-19 vaccine, and one doable unfavourable improvement. Firstly, Pfizer says based mostly on inside testing that its vaccine can tolerate hotter temperatures
www.nasdaq.com